Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 12/20 | 0.70 |
| ▸ | MMP2 | P08253 | 12/20 | 0.70 |
| ▸ | MMP9 | P14780 | 12/20 | 0.70 |
| ▸ | MAOB | P27338 | 5/20 | 0.70 |
| ▸ | EGFR | P00533 | 4/20 | 0.70 |
| ▸ | MAOA | P21397 | 4/20 | 0.70 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6756799 | 0.90 | MMP1 (0.66) | MMP1MMP2MMP9MAOBEGFR | |
| SCHEMBL6754294 | 0.89 | MMP1 (0.64) | MMP1MMP2MMP9MAOBEGFR | |
| SCHEMBL6756820 | 0.86 | MMP1 (0.70) | MMP1MMP2MMP9MAOBEGFR | |
| SCHEMBL6760165 | 0.85 | MMP1 (0.72) | MMP1MMP2MMP9EGFRHDAC6 | |
| SCHEMBL8058288 | 0.85 | MMP1 (0.73) | MMP1MMP2MMP9MAOBEGFR | |
| SCHEMBL8058291 | 0.85 | MMP1 (0.73) | MMP1MMP2MMP9MAOBEGFR | |
| N-M-Tolylcinnamamide SCHEMBL3732520 | 0.83 | MMP1 (1.00) | MMP1MMP2MMP9MAOBEGFR | |
| N-M-Tolylcinnamamide SCHEMBL1601210 | 0.83 | MMP1 (1.00) | MMP1MMP2MMP9MAOBEGFR | |
| N-M-Tolylcinnamamide SCHEMBL3732518 | 0.83 | MMP1 (1.00) | MMP1MMP2MMP9MAOBEGFR | |
| SCHEMBL6756962 | 0.82 | MMP1 (0.64) | MMP1MMP2MMP9MAOBEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040087798-A1 | Novel amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-05-06 | — | — | US | disclosed |
| EP-1264820-A1 | NOVEL AMIDE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087798-A1 | Novel amide compounds | H1-2, H1-0, H1-3 | MMP1 3985/4885MMP2 4187/4885MMP9 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.